NEW YORK, Nov. 27—Gene Logic said Tuesday that it had obtained an exclusive commercial license that will add BioCarta's signal transduction pathway information to its software and database products.
BioCarta, whose core business is in assays and reagents, has also developed a collection of diagrams representing molecular and cellular signal transduction pathways that is available on its interactive website. Gene Logic will add about 150 of these to the next release of its GeneExpress software system, making it the sole commercial database product with this particular set of pathway models.
The pathway data are in a variety of categories, charting pathways involved in immunology, neuroscience, cell cycle regulation, and developmental biology, among others. Each protein in the basic diagram is interactively linked with sequence information, gene maps, and other relevant data.
BioCarta has agreed to update the pathway collections for Gene Logic and provide hundreds of additional charts in the future. Under BioCarta's "Proteomic Pathway Project," updates and additional pathway contributions are provided on an "open source" model, whereby an online community of researchers contributes to maintaining and improving pathway information collected on a public website.
Financial details of the agreement were not disclosed.